Teva Pharmaceutical Industries (TEVA) Debt Ratio (2009 - 2026)
Teva Pharmaceutical Industries' (TEVA) quarterly Debt Ratio came in at 0.42 in Q2 2026, down 3.02% YoY from 0.43 in Q2 2025, and little changed on a QoQ basis from 0.42 in Q1 2026.
Teva Pharmaceutical Industries (TEVA) Debt Ratio (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 18 years of Debt Ratio data on file, last reported at 0.42 in Q2 2026.
- Quarterly Debt Ratio fell 3.02% year-over-year to 0.42 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.42 (down 3.02% YoY) and the FY2025 annual result came in at 0.41, down 8.79% from the prior year.
- Debt Ratio held at 0.42 in Q2 2026, from 0.42 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.49 in Q1 2022 to a low of 0.41 in Q4 2025.
- A 5-year average of 0.45 and a median of 0.46 in 2023 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2023 — Debt Ratio decreased 0.21% — and 2025, when it fell 8.79%.
- Tracing TEVA's Debt Ratio over 5 years: stood at 0.48 in 2022, then decreased by 5.36% to 0.46 in 2023, then declined by 0.87% to 0.45 in 2024, then slipped by 8.79% to 0.41 in 2025, then increased by 0.93% to 0.42 in 2026.
- The last three Debt Ratio figures came in at 0.42 (Q2 2026), 0.42 (Q1 2026), and 0.41 (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 0.12 |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.42 |
| Mar 31, 2026 | 0.42 |
| Dec 31, 2025 | 0.41 |
| Sep 30, 2025 | 0.42 |
| Jun 30, 2025 | 0.43 |
| Mar 31, 2025 | 0.43 |
| Dec 31, 2024 | 0.45 |
| Sep 30, 2024 | 0.45 |
| Jun 30, 2024 | 0.45 |
| Mar 31, 2024 | 0.46 |
| Dec 31, 2023 | 0.46 |
| Sep 30, 2023 | 0.47 |
| Jun 30, 2023 | 0.48 |
| Mar 31, 2023 | 0.48 |
| Dec 31, 2022 | 0.48 |
| Sep 30, 2022 | 0.48 |
| Jun 30, 2022 | 0.48 |
| Mar 31, 2022 | 0.49 |
| Dec 31, 2021 | 0.48 |
| Sep 30, 2021 | 0.50 |